Treatments for CLL patients include chemotherapy, chemoimmunotherapy, and small molecules mostly targeting important signaling pathways in CLL cells (e.g., BCR and BCL2) [8]. Here, BCR is linked to B-cell chronic lymphocytic leukemia.